Issue: Volume XXI No.16 - November 24, 2014

California Hospitals Become Health Insurers

WHAT CHANGES WHEN THE NATION’S HOSPITALS become health insurers? How do pathology practices and clinical laboratories contract to provide lab testing services when their parent hospital is also the insurer? We are about to learn the answers to these questions by watching California. News outlets are reporting that Sutter Health, one of California’s largest integrated …

California Hospitals Become Health Insurers Read More »

Labs Share Successes in Delivering More Value

CEO SUMMARY: As the number of accountable care organizations and patient-centered medical homes grows monthly, a handful of innovative labs are seizing the opportunity to develop and deliver lab testing services that add more value to physicians and patients. These early-adopter labs recognize that fee-for-service reimbursement is on the way out. They want to get …

Labs Share Successes in Delivering More Value Read More »

LipoScience Could Find No Other Interested Buyer than LabCorp

ONE EXAMPLE OF HOW TOUGH TIMES ARE for companies offering proprietary or patent-protected tests is the acquisition of LipoScience by Laboratory Corporation of America in a deal that was disclosed last September. It was announced that LabCorp would pay $85 million, or $5.25 per share, for LipoScience, which analysts said valued the company at just …

LipoScience Could Find No Other Interested Buyer than LabCorp Read More »

Medicare Special Stain LCD May Hinder Pathology Workflow

CEO SUMMARY: Under a proposed rule for Medicare region J-11, a pathologist will no longer be able to use “reflex templates or pre-orders for special stains and/or IHC stains prior to review of the routine H&E.” While the proposed LCD is designed to target a relatively small number of pathologists who regularly overutilize special stains, …

Medicare Special Stain LCD May Hinder Pathology Workflow Read More »

Level Two of Value Pyramid Defines Internal Benchmarks

CEO SUMMARY: In this second installment of our series on the laboratory value pyramid, we introduce “Level Two: Establish and Meet Standards of Value.” This second level continues the lab’s focus on its internal operations and activities. The goal is for the lab to develop the working culture and staff training required to identify relevant …

Level Two of Value Pyramid Defines Internal Benchmarks Read More »

Attorneys Outline Issues in FDA’s LDT Guidance

CEO SUMMARY: Officials at the FDA believe that CLIA does not go far enough because it does not address the issues of whether laboratory-developed tests (LDTs) have been designed correctly or have been manufactured in accordance with sound standards. Also, CLIA does not include a process to verify if LDTs are safe, accurate, or efficacious, …

Attorneys Outline Issues in FDA’s LDT Guidance Read More »

Dark Daily

November 24, 2014 Intelligence: Late Breaking Lab News

Interesting things are unfolding in San Diego with Pathway Genomics, a company with a CLIA lab that offers genetic testing to physicians. On November 12, it was announced that the IBM Watson Group had invested in Pathway Genomics. The two companies said that they are teaming up to deliver “the first-ever cognitive consumer-facing app, based …

November 24, 2014 Intelligence: Late Breaking Lab News Read More »

Powered by Americaneagle.com

Hosted by Americaneagle.com, Inc.